Heartflow, Inc.
HTFLFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Heartflow, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 26, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Heartflow, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-04-30 · Bain Capital Life Sciences Investors, LLC: Larger than 16 of the 17 other insider sales of Common Stock on file. SEC filing
- 2026-02-04 · Bain Capital Life Sciences Investors, LLC: Larger than all 17 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-24 | Farquhar John C.M. · Chief Executive Officer | Common Stock | S — Open market or private sale | −38,900 | 35.00 | SEC filing |
| 2026-06-10 | Farquhar John C.M. · Chief Executive Officer | Common Stock | S — Open market or private sale | −22,562 | 28.50 | SEC filing |
| 2026-05-18 | Rogers Campbell · Chief Medical Officer | Common Stock | S — Open market or private sale | −9,219 | 28.34 | SEC filing |
| 2026-05-11 | Farquhar John C.M. · Chief Executive Officer | Common Stock | S — Open market or private sale | −22,562 | 29.12 | SEC filing |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC · 10% owner | Common Stock | S — Open market or private sale | −56,224 | 30.05 | SEC filing |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC · 10% owner | Common Stock | S — Open market or private sale | −892,533 | 29.18 | SEC filing |
| 2026-04-29 | Bain Capital Life Sciences Investors, LLC · 10% owner | Common Stock | S — Open market or private sale | −797,133 | 29.37 | SEC filing |
| 2026-04-28 | Bain Capital Life Sciences Investors, LLC · 10% owner | Common Stock | S — Open market or private sale | −254,110 | 30.51 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-16 | Lightcap Jeffrey C · Director | Stock Option | A — Grant, award, or other acquisition | +16,075 | SEC filing |
| 2026-06-16 | Tansey Casey M · Director | Stock Option | A — Grant, award, or other acquisition | +16,075 | SEC filing |
| 2026-06-16 | WELDON WILLIAM C · Director | Stock Option | A — Grant, award, or other acquisition | +16,075 | SEC filing |
| 2026-06-16 | BARABE TIMOTHY C · Director | Stock Option | A — Grant, award, or other acquisition | +16,075 | SEC filing |
| 2026-06-16 | Cullivan Julie A · Director | Stock Option | A — Grant, award, or other acquisition | +16,075 | SEC filing |
| 2026-06-16 | Riley Wayne Joseph · Director | Stock Option | A — Grant, award, or other acquisition | +16,075 | SEC filing |
| 2026-06-15 | Rogers Campbell · Chief Medical Officer | Stock Option | M — Exercise or conversion of derivative security | −10,000 | SEC filing |
| 2026-06-15 | Rogers Campbell · Chief Medical Officer | Common Stock | M — Exercise or conversion of derivative security | +10,000 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-24 | HealthCor Partners Management LP · Director | COMMON STOCK | J — Other acquisition or disposition | −4,615,542 | SEC filing |
| 2026-03-24 | Lightcap Jeffrey C · Director | Common Stock | J — Other acquisition or disposition | +206,261 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.